Lisa Egbuonu-Davis, a director at Phreesia, Inc. (NASDAQ:PHR), sold 536 shares of the company’s common stock on July 14, 2026. The transaction totaled $5,735, with shares sold at a price of $10.70 each. The stock currently trades at $10.85, well below its 52-week high of $32.76 but above its low of $7.77.
Following this sale, Ms. Egbuonu-Davis directly holds 37,780 shares of Phreesia common stock. The transaction was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Ms. Egbuonu-Davis on December 16, 2025. According to InvestingPro, Phreesia appears undervalued at current levels, with analysts predicting profitability this year. The platform offers additional insights through its comprehensive Pro Research Report, available for PHR and 1,400+ other US equities.
In other recent news, Phreesia Inc. reported its first-quarter fiscal 2027 earnings, surpassing expectations with an EPS of $0.05, significantly higher than the forecasted $0.01. The company also achieved total revenue of $130.9 million, slightly above the consensus estimate of $130.1 million. Adjusted EBITDA was reported at $30.5 million, exceeding the expected $28.4 million. Following these results, Citizens maintained its Market Perform rating on Phreesia, while DA Davidson reiterated a Buy rating with a $14.00 price target.
In contrast, Piper Sandler downgraded Phreesia to Neutral from Overweight, adjusting its price target to $12 from $23, due to a shift in profitability outlook. Truist Securities, meanwhile, raised its price target on Phreesia to $12.00 from $11.00, maintaining a Hold rating. Truist’s revenue estimates for fiscal years 2027 and 2028 remain largely unchanged. These developments reflect varied analyst reactions to Phreesia’s financial performance and future outlook.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
